Search Results - "Wellman, Jennifer A."
-
1
Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B
Published in Molecular therapy (02-09-2020)“…Adeno-associated virus (AAV) vectors are a leading platform for gene-based therapies for both monogenic and complex acquired disorders. The success of AAV gene…”
Get full text
Journal Article -
2
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials
Published in Ophthalmology (Rochester, Minn.) (01-09-2019)“…To report the durability of voretigene neparvovec-rzyl (VN) adeno-associated viral vector-based gene therapy for RPE65 mutation-associated inherited retinal…”
Get full text
Journal Article -
3
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Published in The Lancet (British edition) (26-08-2017)“…Phase 1 studies have shown potential benefit of gene replacement in RPE65-mediated inherited retinal dystrophy. This phase 3 study assessed the efficacy and…”
Get full text
Journal Article -
4
The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene
Published in American journal of ophthalmology (01-03-2019)“…To delineate the natural history of visual parameters over time in individuals with biallelic RPE65 mutation–associated inherited retinal dystrophy (IRD);…”
Get full text
Journal Article -
5
Genetic Medicine for Hearing Loss: OTOF as Exemplar
Published in Journal of the American Academy of Audiology (01-11-2021)“…Millions of people worldwide have disabling hearing loss because one of their genes generates an incorrect version of some specific protein the ear requires…”
Get more information
Journal Article -
6
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy
Published in Ophthalmology (Rochester, Minn.) (01-09-2019)“…To report the durability of voretigene neparvovec-rzyl (VN) adeno-associated viral vector–based gene therapy for RPE65 mutation–associated inherited retinal…”
Get full text
Journal Article -
7
Year 3 results and age-stratified analyses for a phase 3 trial of voretigene neparvovec in RPE65 mutation-associated inherited retinal disease
Published in Journal of AAPOS (01-08-2018)Get full text
Journal Article